141 related articles for article (PubMed ID: 11405652)
1. Synthesis of novel gamma-aminobutyric acid (GABA) uptake inhibitors. 5.(1) Preparation and structure-activity studies of tricyclic analogues of known GABA uptake inhibitors.
Andersen KE; Sørensen JL; Lau J; Lundt BF; Petersen H; Huusfeldt PO; Suzdak PD; Swedberg MD
J Med Chem; 2001 Jun; 44(13):2152-63. PubMed ID: 11405652
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel GABA uptake inhibitors. 4. Bioisosteric transformation and successive optimization of known GABA uptake inhibitors leading to a series of potent anticonvulsant drug candidates.
Andersen KE; Sørensen JL; Huusfeldt PO; Knutsen LJ; Lau J; Lundt BF; Petersen H; Suzdak PD; Swedberg MD
J Med Chem; 1999 Oct; 42(21):4281-91. PubMed ID: 10543872
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel GABA uptake inhibitors. Part 6: preparation and evaluation of N-Omega asymmetrically substituted nipecotic acid derivatives.
Andersen KE; Lau J; Lundt BF; Petersen H; Huusfeldt PO; Suzdak PD; Swedberg MD
Bioorg Med Chem; 2001 Nov; 9(11):2773-85. PubMed ID: 11597457
[TBL] [Abstract][Full Text] [Related]
4. The synthesis of novel GABA uptake inhibitors. 1. Elucidation of the structure-activity studies leading to the choice of (R)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic acid (tiagabine) as an anticonvulsant drug candidate.
Andersen KE; Braestrup C; Grønwald FC; Jørgensen AS; Nielsen EB; Sonnewald U; Sørensen PO; Suzdak PD; Knutsen LJ
J Med Chem; 1993 Jun; 36(12):1716-25. PubMed ID: 8510100
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel GABA uptake inhibitors. 3. Diaryloxime and diarylvinyl ether derivatives of nipecotic acid and guvacine as anticonvulsant agents.
Knutsen LJ; Andersen KE; Lau J; Lundt BF; Henry RF; Morton HE; Naerum L; Petersen H; Stephensen H; Suzdak PD; Swedberg MD; Thomsen C; Sørensen PO
J Med Chem; 1999 Sep; 42(18):3447-62. PubMed ID: 10479278
[TBL] [Abstract][Full Text] [Related]
6. NNC-711, a novel potent and selective gamma-aminobutyric acid uptake inhibitor: pharmacological characterization.
Suzdak PD; Frederiksen K; Andersen KE; Sørensen PO; Knutsen LJ; Nielsen EB
Eur J Pharmacol; 1992 Dec; 224(2-3):189-98. PubMed ID: 1468507
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity studies on benzhydrol-containing nipecotic acid and guvacine derivatives as potent, orally-active inhibitors of GABA uptake.
Pavia MR; Lobbestael SJ; Nugiel D; Mayhugh DR; Gregor VE; Taylor CP; Schwarz RD; Brahce L; Vartanian MG
J Med Chem; 1992 Oct; 35(22):4238-48. PubMed ID: 1433224
[TBL] [Abstract][Full Text] [Related]
8. Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor.
Nielsen EB; Suzdak PD; Andersen KE; Knutsen LJ; Sonnewald U; Braestrup C
Eur J Pharmacol; 1991 Apr; 196(3):257-66. PubMed ID: 1832636
[TBL] [Abstract][Full Text] [Related]
9. A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor.
Suzdak PD; Jansen JA
Epilepsia; 1995 Jun; 36(6):612-26. PubMed ID: 7555976
[TBL] [Abstract][Full Text] [Related]
10. GABA uptake inhibitors containing mono- and diarylmethoxyalkyl N-substituents.
Falch E; Krogsgaard-Larsen P
Drug Des Deliv; 1989 May; 4(3):205-15. PubMed ID: 2535204
[TBL] [Abstract][Full Text] [Related]
11. Effects of two convulsant beta-carboline derivatives, DMCM and beta-CCM, on regional neurotransmitter amino acid levels and on in vitro D-[3H]aspartate release in rodents.
Chapman AG; Cheetham SC; Hart GP; Meldrum BS; Westerberg E
J Neurochem; 1985 Aug; 45(2):370-81. PubMed ID: 2861248
[TBL] [Abstract][Full Text] [Related]
12. GABA agonists and uptake inhibitors. Synthesis, absolute stereochemistry, and enantioselectivity of (R)-(-)- and (S)-(+)-homo-beta-proline.
Nielsen L; Brehm L; Krogsgaard-Larsen P
J Med Chem; 1990 Jan; 33(1):71-7. PubMed ID: 2153214
[TBL] [Abstract][Full Text] [Related]
13. GABA-level increasing and anticonvulsant effects of three different GABA uptake inhibitors.
Dalby NO
Neuropharmacology; 2000 Sep; 39(12):2399-407. PubMed ID: 10974324
[TBL] [Abstract][Full Text] [Related]
14. Anticonvulsant properties of two GABA uptake inhibitors NNC 05-2045 and NNC 05-2090, not acting preferentially on GAT-1.
Dalby NO; Thomsen C; Fink-Jensen A; Lundbeck J; Søkilde B; Man CM; Sørensen PO; Meldrum B
Epilepsy Res; 1997 Jul; 28(1):51-61. PubMed ID: 9255599
[TBL] [Abstract][Full Text] [Related]
15. Novel inhibitors of gamma-aminobutyric acid (GABA) uptake: anticonvulsant actions in rats and mice.
Yunger LM; Fowler PJ; Zarevics P; Setler PE
J Pharmacol Exp Ther; 1984 Jan; 228(1):109-15. PubMed ID: 6694095
[TBL] [Abstract][Full Text] [Related]
16. First demonstration of a functional role for central nervous system betaine/{gamma}-aminobutyric acid transporter (mGAT2) based on synergistic anticonvulsant action among inhibitors of mGAT1 and mGAT2.
White HS; Watson WP; Hansen SL; Slough S; Perregaard J; Sarup A; Bolvig T; Petersen G; Larsson OM; Clausen RP; Frølund B; Falch E; Krogsgaard-Larsen P; Schousboe A
J Pharmacol Exp Ther; 2005 Feb; 312(2):866-74. PubMed ID: 15550575
[TBL] [Abstract][Full Text] [Related]
17. The gamma-aminobutyric acid uptake inhibitor, tiagabine, is anticonvulsant in two animal models of reflex epilepsy.
Smith SE; Parvez NS; Chapman AG; Meldrum BS
Eur J Pharmacol; 1995 Feb; 273(3):259-65. PubMed ID: 7737333
[TBL] [Abstract][Full Text] [Related]
18. Correlation between anticonvulsant activity and inhibitory action on glial gamma-aminobutyric acid uptake of the highly selective mouse gamma-aminobutyric acid transporter 1 inhibitor 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole and its N-alkylated analogs.
White HS; Sarup A; Bolvig T; Kristensen AS; Petersen G; Nelson N; Pickering DS; Larsson OM; Frølund B; Krogsgaard-Larsen P; Schousboe A
J Pharmacol Exp Ther; 2002 Aug; 302(2):636-44. PubMed ID: 12130726
[TBL] [Abstract][Full Text] [Related]
19. GABA uptake inhibitors. Design, molecular pharmacology and therapeutic aspects.
Krogsgaard-Larsen P; Frølund B; Frydenvang K
Curr Pharm Des; 2000 Aug; 6(12):1193-209. PubMed ID: 10903390
[TBL] [Abstract][Full Text] [Related]
20. Orally active and potent inhibitors of gamma-aminobutyric acid uptake.
Ali FE; Bondinell WE; Dandridge PA; Frazee JS; Garvey E; Girard GR; Kaiser C; Ku TW; Lafferty JJ; Moonsammy GI
J Med Chem; 1985 May; 28(5):653-60. PubMed ID: 2985785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
